These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10575336)

  • 1. Length and lead time biases in radiologic screening for lung cancer.
    Soda H; Oka M; Tomita H; Nagashima S; Soda M; Kohno S
    Respiration; 1999; 66(6):511-7. PubMed ID: 10575336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological characteristics of screen-detected lung cancers.
    Kawachi R; Watanabe S; Asamura H
    J Thorac Oncol; 2009 May; 4(5):615-9. PubMed ID: 19318993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The natural history of radiographically occult bronchogenic squamous cell carcinoma: a retrospective study of overdiagnosis bias.
    Sato M; Saito Y; Endo C; Sakurada A; Feller-Kopman D; Ernst A; Kondo T
    Chest; 2004 Jul; 126(1):108-13. PubMed ID: 15249450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling.
    Wille MM; Dirksen A; Ashraf H; Saghir Z; Bach KS; Brodersen J; Clementsen PF; Hansen H; Larsen KR; Mortensen J; Rasmussen JF; Seersholm N; Skov BG; Thomsen LH; Tønnesen P; Pedersen JH
    Am J Respir Crit Care Med; 2016 Mar; 193(5):542-51. PubMed ID: 26485620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitation of annual screening chest radiography for the diagnosis of lung cancer. A retrospective study.
    Soda H; Tomita H; Kohno S; Oka M
    Cancer; 1993 Oct; 72(8):2341-6. PubMed ID: 8402447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving survival for stage IV non-small cell lung cancer: a surveillance, epidemiology, and end results survey from 1990 to 2005.
    Morgensztern D; Waqar S; Subramanian J; Gao F; Govindan R
    J Thorac Oncol; 2009 Dec; 4(12):1524-9. PubMed ID: 19752759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers.
    Lindell RM; Hartman TE; Swensen SJ; Jett JR; Midthun DE; Tazelaar HD; Mandrekar JN
    Radiology; 2007 Feb; 242(2):555-62. PubMed ID: 17255425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic impact of sex on surgically resected non-small cell lung cancer depends on clinicopathologic characteristics.
    Sterlacci W; Tzankov A; Veits L; Oberaigner W; Schmid T; Hilbe W; Fiegl M
    Am J Clin Pathol; 2011 Apr; 135(4):611-8. PubMed ID: 21411784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of patients with lung cancer detected by mass screening versus presentation with symptoms.
    Satoh H; Ishikawa H; Yamashita YT; Naito T; Takahashi H; Kamma H; Saito Y; Ohtsuka M; Hasegawa S
    Anticancer Res; 1997; 17(3C):2293-6. PubMed ID: 9216704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002.
    Sawabata N; Asamura H; Goya T; Mori M; Nakanishi Y; Eguchi K; Koshiishi Y; Okumura M; Miyaoka E; Fujii Y;
    J Thorac Oncol; 2010 Sep; 5(9):1369-75. PubMed ID: 20683209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of lung cancer mass screening on surgical results.
    Koike T; Terashima M; Takizawa T; Haga M; Kurita Y; Yokoyama A; Misawa H
    Lung Cancer; 1999 May; 24(2):75-80. PubMed ID: 10444057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the ¹⁸f-fluorodeoxyglucose-positron emission tomography scan in the Nederlands Leuvens Longkanker screenings Onderzoek lung cancer screening trial.
    van't Westeinde SC; de Koning HJ; Thunnissen FB; Oudkerk M; Groen HJ; Lammers JW; Weenink C; Vernhout R; Nackaerts K; Mali W; van Klaveren RJ
    J Thorac Oncol; 2011 Oct; 6(10):1704-12. PubMed ID: 21876458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of combined interpretation of computed tomography response and positron emission tomography response for prediction of prognosis after neoadjuvant chemotherapy in non-small cell lung cancer.
    Lee HY; Lee HJ; Kim YT; Kang CH; Jang BG; Chung DH; Goo JM; Park CM; Lee CH; Kang KW
    J Thorac Oncol; 2010 Apr; 5(4):497-503. PubMed ID: 20195167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of patients with lung cancer found in a single chest radiograph screening.
    Salomaa ER; Liippo K; Taylor P; Palmgren J; Haapakoski J; Virtamo J; Heinonen OP
    Chest; 1998 Dec; 114(6):1514-8. PubMed ID: 9872181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cavitating squamous cell lung carcinoma-distinct entity or not? Analysis of radiologic, histologic, and clinical features.
    Pentheroudakis G; Kostadima L; Fountzilas G; Kalogera-Fountzila A; Klouvas G; Kalofonos C; Pavlidis N
    Lung Cancer; 2004 Sep; 45(3):349-55. PubMed ID: 15301875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small median tumor diameter at cure threshold (<20 mm) among aggressive non-small cell lung cancers in male smokers predicts both chest X-ray and CT screening outcomes in a novel simulation framework.
    Goldwasser DL; Kimmel M
    Int J Cancer; 2013 Jan; 132(1):189-97. PubMed ID: 22510979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung cancer chemotherapy. Response-survival relationship depends on the method of chest tumor response evaluation.
    Pujol JL; Parrat E; Lehmann M; Gautier V; Daurès JP; Michel FB; Godard P
    Am J Respir Crit Care Med; 1996 Jan; 153(1):243-9. PubMed ID: 8542123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time trends of overall survival and survival after recurrence in completely resected stage I non-small cell lung cancer.
    Hung JJ; Jeng WJ; Hsu WH; Huang BS; Wu YC
    J Thorac Oncol; 2012 Feb; 7(2):397-405. PubMed ID: 22173701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe.
    Inoue M; Sawabata N; Takeda S; Ohta M; Ohno Y; Maeda H
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1100-6. PubMed ID: 15052208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of M1a Non-Small Cell Lung Cancer Treated Surgically: A Retrospective Single-Center Study.
    Liu T; Liu H; Wang G; Zhang C; Liu B
    Thorac Cardiovasc Surg; 2015 Oct; 63(7):577-82. PubMed ID: 25893920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.